✦ LIBER ✦

Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura

✍ Scribed by Shailendra Kapoor

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 67 KB
Volume: 27
Category: Article
ISSN: 0929-5305
DOI: 10.1007/s11239-008-0224-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab for the treatment of refractor

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases

✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp

Rituximab in the management of chronic i

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

✍ On behalf of the Multi-institutional Retrospective Spanish Study on the use of r 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 125 KB

Rituximab in the management of chronic i

Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients

✍ F. J. Peñalver; V. Jimenez-Yuste; M. Almagro; A. Alvarez-Larrán; L. Rodríguez; M 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 48 KB